The dividend yield investors could receive from Pfizer stock has risen from about 3% in early 2022 to 7% when the market closed on Aug. 5, 2025. Reliable dividend-paying stocks like Pfizer generally don't offer yields this high unless there's a reason to be concerned about the underlying business.

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday. CEO Albert Bourla also said the company has been in active discussions with members of the U.

Pfizer bucked the trend of a tepid big pharma Q2 window, raising its full-year profit forecast on the back of strong sales for heart disease drug Vyndaqel (tafamidis) and blood thinner Eliquis (apixaban),